| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |